Skip to main content
Telo Genomics Corp. logo

Telo Genomics Corp. — Investor Relations & Filings

Ticker · TELO TSXV Professional, scientific and technical activities
Filings indexed 198 across all filing types
Latest filing 2024-10-25 Regulatory Filings
Country CA Canada
Listing TSXV TELO

About Telo Genomics Corp.

https://www.telodx.com/

Telo Genomics Corp. is a molecular diagnostics company specializing in developing predictive and prognostic solutions utilizing its proprietary telomere-based platform. The core technology, TeloView®, quantifies genomic instability by measuring the 3D structure and spatial organization of telomeres. This platform is designed to provide actionable information regarding disease aggressiveness and potential response to treatment, helping to tailor therapeutic approaches. Applications focus primarily on multiple cancers (oncology) and neurodegenerative diseases (CNS). The company is pioneering the most comprehensive telomere platform in the industry to address unmet market needs.

Recent filings

Filing Released Lang Actions
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).PDF
Regulatory Filings
2024-10-25 English
Audited annual financial statements – English.pdf
Regulatory Filings
2024-10-25 English
News release - English.pdf
Regulatory Filings
2024-10-22 English
Notice of the meeting and record date - English.pdf
Regulatory Filings
2024-09-24 English
News release - English.pdf
Regulatory Filings
2024-09-10 English
News release - English.pdf
Regulatory Filings
2024-08-13 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.